Literature DB >> 28111008

Primary Intraventricular Hemorrhage: Clinical Characteristics and Outcomes.

Rachel Weinstein1, Kathryn Ess1, Bilaal Sirdar1, Sarah Song1, Shawna Cutting2.   

Abstract

BACKGROUND: Primary intraventricular hemorrhage (IVH) in adults is a rare neurologic disorder. The typical course, etiology, complications, and outcomes have not been well established.
MATERIALS AND METHODS: Consecutive patient records with a diagnosis of intracerebral hemorrhage admitted between May 2009 and June 2014 at a tertiary care center were retrospectively reviewed. Subjects were included in the study cohort if all neurologists and the radiology report agreed that the subject had an isolated IVH. Patients with intraparenchymal hemorrhage, subarachnoid hemorrhage, malignancy with hemorrhagic components, and hemorrhagic transformation of ischemic stroke were excluded. The electronic medical record, imaging report, and imaging studies were reviewed.
FINDINGS: Of 1692 cases reviewed, 33 (1.9%) had primary IVH. The most common presenting symptoms included altered mental status (48.5%), headache, (39.4%), and nausea (24.2%). In 36.3%, hypertension was found to be a contributing factor; 27.2% were attributed solely to hypertension. Vascular abnormalities were the primary etiology in 21.3% of patients. When observing outcomes, 61.8% were discharged home or to rehab, whereas 20.5% died or were placed in hospice care. A higher Graeb score was associated with an increased likelihood of death or hospice (8 versus 5, P = .02)
CONCLUSION: This study is one of few to describe the etiology, contributing factors, and outcomes of primary IVH. As in prior studies, hypertension was a contributing factor, and vascular lesions were less common than expected. More research is necessary to further define the course and characteristics of this rare type of intracerebral hemorrhage.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Graeb score; Intraventricular hemorrhage; arteriovenous malformation; cerebral angiography; hydrocephalus; intracranial hemorrhage; outcome

Mesh:

Year:  2017        PMID: 28111008     DOI: 10.1016/j.jstrokecerebrovasdis.2016.11.114

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Primary intraventricular hemorrhage outcomes in the CLEAR III trial.

Authors:  Sarah E Nelson; W Andrew Mould; Dheeraj Gandhi; Richard E Thompson; Sarah Salter; Rachel Dlugash; Issam A Awad; Daniel F Hanley; Wendy Ziai
Journal:  Int J Stroke       Date:  2020-02-19       Impact factor: 5.266

2.  Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.

Authors:  Robert J Stanton; Mark H Eckman; Daniel Woo; Charles J Moomaw; Mary Haverbusch; Matthew L Flaherty; Dawn O Kleindorfer
Journal:  Stroke       Date:  2020-01-31       Impact factor: 7.914

3.  Hemorrhagic Neurologic Manifestations in COVID-19: An Isolated or Multifactorial Cause?

Authors:  P S Dhillon; A Chattopadhyay; R A Dineen; R Lenthall
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-08       Impact factor: 3.825

Review 4.  Hypertensive primary intraventricular hemorrhage: a systematic review.

Authors:  Luis A Robles; Victor Volovici
Journal:  Neurosurg Rev       Date:  2022-02-20       Impact factor: 3.042

5.  Clinical features and prognostic factors in patients with intraventricular hemorrhage caused by ruptured arteriovenous malformations.

Authors:  Zengpanpan Ye; Xiaolin Ai; Xin Hu; Fang Fang; Chao You
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.